Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Development ; 127(24): 5403-13, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11076761

ABSTRACT

In olfactory epithelium (OE) cultures, bone morphogenetic proteins (BMPs) can strongly inhibit neurogenesis. Here we provide evidence that BMPs also promote, and indeed are required, for OE neurogenesis. Addition of the BMP antagonist noggin inhibited neurogenesis in OE-stromal cell co-cultures. Bmp2, Bmp4 and Bmp7 were expressed by OE stroma, and low concentrations of BMP4 (below the threshold for inhibition of neurogenesis) stimulated neurogenesis; BMP7 did not exhibit a stimulatory effect at any concentration tested. Stromal cell conditioned medium also stimulated neurogenesis; part of this effect was due to the presence within it of a noggin-binding factor or factors. Studies of the pro-neurogenic effect of BMP4 indicated that it did not increase progenitor cell proliferation, but rather promoted survival of newly generated olfactory receptor neurons. These findings indicate that BMPs exert both positive and negative effects on neurogenesis, depending on ligand identity, ligand concentration and the particular cell in the lineage that is responding. In addition, they reveal the presence of a factor or factors, produced by OE stroma, that can synergize with BMP4 to stimulate OE neurogenesis.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Olfactory Receptor Neurons/drug effects , Olfactory Receptor Neurons/embryology , Transforming Growth Factor beta , Animals , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Protein 7 , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/physiology , Carrier Proteins , Cell Survival/drug effects , Cells, Cultured , Culture Media, Conditioned , Gene Expression , Humans , Mice , Olfactory Receptor Neurons/metabolism , Proteins/genetics , Proteins/pharmacology , Proteins/physiology , Recombinant Proteins/pharmacology , Stem Cells/drug effects , Stromal Cells/metabolism
2.
Nat Cell Biol ; 2(9): 666-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10980709

ABSTRACT

This study was carried out to discriminate between two alternative hypotheses as to how cells sense mechanical forces and transduce them into changes in gene transcription. Do cells sense mechanical signals through generalized membrane distortion or through specific transmembrane receptors, such as integrins? Here we show that mechanical stresses applied to the cell surface alter the cyclic AMP signalling cascade and downstream gene transcription by modulating local release of signals generated by activated integrin receptors in a G-protein-dependent manner, whereas distortion of integrins in the absence of receptor occupancy has no effect.


Subject(s)
Cyclic AMP/metabolism , Integrin beta1/metabolism , Signal Transduction/physiology , Transcription, Genetic , 3T3 Cells , Animals , Cattle , Cells, Cultured , Cyclic AMP Response Element-Binding Protein/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Endothelium, Vascular/cytology , Gene Expression Regulation , Mice , Physical Stimulation
3.
Nat Neurosci ; 2(4): 339-45, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10204540

ABSTRACT

Bone morphogenetic proteins (BMPs), negative regulators of neural determination in the early embryo, were found to be potent inhibitors of neurogenesis in olfactory epithelium (OE) cultures. BMPs 2, 4 or 7 decreased the number of proliferating progenitor cells and blocked production of olfactory receptor neurons (ORNs). Experiments suggested that this effect was due to an action of BMPs on an early-stage progenitor in the ORN lineage. Further analysis revealed that progenitors exposed to BMPs rapidly (< 2 h) lost MASH1, a transcription factor known to be required for the production of ORNs. This disappearance was due to proteolysis of existing MASH1 protein, but new gene expression was required to trigger it. The data suggest a novel mechanism of BMP action, whereby the induced degradation of an essential transcription factor results in premature termination of a neuronal lineage.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Developmental/drug effects , Olfactory Receptor Neurons/metabolism , Transcription Factors/metabolism , Transforming Growth Factor beta , Animals , Basic Helix-Loop-Helix Transcription Factors , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Protein 7 , Cell Division/drug effects , Cell Lineage , Colony-Forming Units Assay , Culture Media, Conditioned/pharmacology , Cysteine Endopeptidases/metabolism , Mice , Mice, Transgenic , Multienzyme Complexes/metabolism , Olfactory Receptor Neurons/cytology , Proteasome Endopeptidase Complex
4.
J Neurobiol ; 36(2): 190-205, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9712304

ABSTRACT

The vertebrate olfactory epithelium (OE) is a system in which behavior of neuronal progenitor cells can be observed and manipulated easily. It is morphologically and functionally similar to embryonic germinal neuroepithelia, but is simpler in that it produces large numbers of a single type of neuron, the olfactory receptor neuron (ORN). The OE is amenable to tissue culture, gene transfer, and in vivo surgical approaches, and these have been exploited in experiments aimed at understanding the characteristics of OE neuronal progenitor cells. This has led to the realization that the ORN lineage contains at least three distinct stages of proliferating neuronal progenitor cells (including a stem cell), each of which represents a point at which growth control can be exerted. Neurogenesis proceeds continually in the OE, and studies in vivo have shown that this is a regulated process that serves to maintain the number of ORNs at a particular level. These studies suggest that OE neuronal progenitors-which are in close physical proximity to ORNs-can "read" the number of differentiated neurons in their environment and regulate production of new neurons accordingly. Putative neuronal stem cells of the OE have been identified in vitro, and studies of these cells indicate that ORNs produce a signal that feeds back to inhibit neurogenesis. This inhibitory signal may be exerted at the level of the stem cell itself. Recent studies to identify this signal, as well as endogenous stimulatory signals that may be important in regulating OE neurogenesis, are also discussed.


Subject(s)
Neurons/physiology , Olfactory Mucosa/cytology , Stem Cells/physiology , Animals , Cell Communication/physiology , Cell Division/physiology , Cell Line/physiology
5.
Ann N Y Acad Sci ; 855: 226-9, 1998 Nov 30.
Article in English | MEDLINE | ID: mdl-9929610

ABSTRACT

To identify factors regulating neurogenesis and programmed cell death in mouse olfactory epithelium (OE), and to determine the mechanisms by which these factors act, we have studied mouse OE using two major experimental paradigms: tissue culture of embryonic OE and cell types isolated from it; and ablation of the olfactory bulb ('bulbectomy') of adult mice, a procedure that induces programmed cell death of olfactory receptor neurons (ORNS) and a subsequent surge of neurogenesis in the OE in vivo. Such experiments have been used to characterize the cellular stages in the ORN lineage, leading to the realization that there are at least two distinct stages of proliferating neuronal progenitor cells interposed between the ORN and the stem cell that ultimately gives rise to it. The identification of a number of different factors that act to regulate proliferation and survival of ORNs and progenitor cells suggests that these multiple cell stages may each serve as a control point at which neuron number in the OE is regulated. Our recent studies of neuronal colony-forming progenitors (putative stem cells) of the OE suggest that even these cells, at the earliest stage in the ORN lineage so far identified, are subject to such regulation: if colony-forming progenitors are cultured in the presence of a large excess of differentiated ORNs, then the production of new neurons by progenitors is dramatically inhibited. This result suggests that differentiated ORNs produce a signal that feeds back to inhibit neurogenesis by their own progenitors, and provides a possible explanation for the observation that ORN death, consequent to bulbectomy, results in increased neurogenesis in the OE in vivo: death of ORNs may release neuronal progenitor cells from this inhibitory signal, produced by the differentiated ORNs that lie near them in the OE. Our current experiments are directed toward identifying the molecular basis of this inhibitory signal, and the cellular mechanism(s) by which it acts.


Subject(s)
Apoptosis , Epithelial Cells/pathology , Olfactory Receptor Neurons/cytology , Animals , Cell Differentiation , Cell Lineage/physiology , Mice , Olfactory Mucosa/pathology , Olfactory Mucosa/physiology , Paracrine Communication
6.
Clin Cancer Res ; 2(11): 1867-71, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9816142

ABSTRACT

Angiogenesis plays a critical role in tumor biology and may someday be a target for novel therapeutic interventions. To date, however, relatively few markers have been identified that can specifically distinguish between microvessels in benign versus malignant lesions. Here we report that the cationic heme-protein eosinophil peroxidase (EPO) was localized by in situ immunohistochemistry on the vascular endothelial cells and/or connective tissue stroma in 16 of 16 cases of human endometrial carcinoma and in 12 of 15 cases of ovarian carcinoma. Similar deposits of EPO were not detected in normal endometrial tissues or ovaries from five healthy subjects, in adjacent uninvolved tissues from four tumor-bearing subjects, or in any normal organs from five other subjects. These findings imply that eosinophil degranulation is a significant and previously unappreciated component of the interaction between ovarian and endometrial cancers and the host. Moreover, the abundant and highly specific nature of the EPO deposition near and within the microvessels of these cancers suggests that eosinophil degranulation is a new marker for tumor blood vessels that potentially could be exploited to treat these important types of cancers that currently lack highly effective therapies.


Subject(s)
Adenocarcinoma/blood supply , Blood Vessels/enzymology , Endometrial Neoplasms/blood supply , Ovarian Neoplasms/blood supply , Peroxidases/analysis , Adenocarcinoma/chemistry , Adenocarcinoma/pathology , Endometrial Neoplasms/chemistry , Endometrial Neoplasms/pathology , Eosinophil Peroxidase , Female , Humans , Immunohistochemistry , Ovarian Neoplasms/chemistry , Ovarian Neoplasms/pathology , Peroxidases/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...